Drug Trial Radar · NCT07392177
Understanding the Role of the Locus Coeruleus in Insomnia
Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Aug 12, 2026
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Woolcock Institute of Medical ResearchAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 30 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This research project aims to better understand the neurobiological mechanistic underpinnings of insomnia disorder. The main question is whether cortical hyperarousal in individuals with insomnia disorder, measured by electroencephalograhic (EEG) infraslow oscillation coupling of sigma power during non-rapid eye movement (NREM) sleep and theta power during rapid eye movement (REM) sleep, is related to locus coeruleus activity.
Conditions
- Insomnia
Interventions
DexmedetomidineDrug
A buccal tablet containing 96 µg dexmedetomidine will be taken before habitual bedtime.
PlaceboDrug
Placebo tablets will contain identical excipient without the active ingredient (dexmedetomidine) and manufactured under the same condition as the active. Placebo tablets, packs and instructions will be identical in every respect to enable the double-blind study design.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Electrographic (EEG) signaturesTime frame: Baseline and 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Woolcock Institute of Medical Research
Macquarie Park, New South Wales, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.